{"id":"NCT01863680","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel","officialTitle":"Open-label, Single-arm, Multicenter Phase III Trial to Evaluate the Efficacy and Safety of COL-1620 8% Vaginal Progesterone Gel for Luteal Phase Support in In-vitro Fertilization and Embryo Transfer (IVF/ET) Cycles in Japanese Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2014-10","completion":"2014-10","firstPosted":"2013-05-29","resultsPosted":"2015-12-21","lastUpdate":"2015-12-21"},"enrollment":178,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Luteal Hormone Supplementation in In-vitro Fertilization","Embryo Transfer"],"interventions":[{"type":"DRUG","name":"COL-1620","otherNames":[]},{"type":"DRUG","name":"Gonadotropin-releasing hormone (GnRH) analogue","otherNames":[]},{"type":"DRUG","name":"Follicle-stimulating hormone (FSH)","otherNames":[]},{"type":"DRUG","name":"Human Chorionic Gonadotropin (hCG)","otherNames":[]}],"arms":[{"label":"COL-1620","type":"EXPERIMENTAL"}],"summary":"The primary objective of this trial is to demonstrate the non-inferiority of the clinical pregnancy rate per embryo transfer to the historical standard value in in-vitro fertilization (IVF)/embryo transfer (ET) cycles in Japan (Japan Society of Obstetrics and Gynecology \\[JSOG\\] 2009 registry data: 24.3 percent \\[%\\]). The secondary objectives of this trial are to assess the biochemical pregnancy rate per ET, pharmacokinetics, and safety of COL-1620.","primaryOutcome":{"measure":"Clinical Pregnancy Rate Per Embryo Transfer","timeFrame":"Week 5 post embryo transfer (2-6 days after Ovum Pick-up [OPU])","effectByArm":[{"arm":"COL-1620","deltaMin":28.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":19},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":149},"commonTop":["Ovarian hyperstimulation syndrome","Constipation","Abdominal pain","Diarrhoea","Hyperemesis gravidarum"]}}